• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Baird Medical Investment Holdings Ltd

    12/5/25 4:03:02 PM ET
    $BDMD
    Medical/Dental Instruments
    Health Care
    Get the next $BDMD alert in real time by email
    Baird Medical Investment Holdings Limited_2025-06-30
    0001982444--12-312025Q22025-06-30false00019824442025-01-012025-06-300001982444us-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-300001982444us-gaap:CommonStockMember2025-01-012025-06-300001982444bdmd:ExcelFinSpacLlcMember2023-08-032023-08-030001982444us-gaap:NoncontrollingInterestMember2025-06-300001982444us-gaap:NoncontrollingInterestMember2024-12-310001982444us-gaap:NoncontrollingInterestMember2024-06-300001982444us-gaap:NoncontrollingInterestMember2023-12-310001982444us-gaap:RetainedEarningsMember2025-06-300001982444us-gaap:ParentMember2025-06-300001982444us-gaap:AdditionalPaidInCapitalMember2025-06-300001982444us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001982444bdmd:StatutoryReserveMember2025-06-300001982444us-gaap:RetainedEarningsMember2024-12-310001982444us-gaap:ParentMember2024-12-310001982444us-gaap:AdditionalPaidInCapitalMember2024-12-310001982444us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001982444bdmd:StatutoryReserveMember2024-12-310001982444us-gaap:RetainedEarningsMember2024-06-300001982444us-gaap:ParentMember2024-06-300001982444us-gaap:AdditionalPaidInCapitalMember2024-06-300001982444us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001982444bdmd:StatutoryReserveMember2024-06-300001982444us-gaap:RetainedEarningsMember2023-12-310001982444us-gaap:ParentMember2023-12-310001982444us-gaap:AdditionalPaidInCapitalMember2023-12-310001982444us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001982444bdmd:StatutoryReserveMember2023-12-310001982444us-gaap:PreferredStockMember2025-06-300001982444us-gaap:CommonStockMember2025-06-300001982444us-gaap:PreferredStockMember2024-12-310001982444us-gaap:CommonStockMember2024-12-310001982444us-gaap:CommonStockMember2024-06-300001982444us-gaap:CommonStockMember2023-12-310001982444us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMemberbdmd:EquityIncentivePlan2024Member2025-01-012025-06-300001982444us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberbdmd:EquityIncentivePlan2024Member2025-01-012025-06-300001982444bdmd:BaideSuzhouMember2025-06-3000019824442025-01-012025-06-300001982444us-gaap:TransferredOverTimeMember2025-01-012025-06-300001982444us-gaap:TransferredAtPointInTimeMember2025-01-012025-06-300001982444bdmd:OtherMedicalDevicesMember2025-01-012025-06-300001982444bdmd:MicrowaveAblationTherapeuticApparatusMember2025-01-012025-06-300001982444bdmd:MicrowaveAblationNeedlesMember2025-01-012025-06-300001982444bdmd:MicrowaveAblationDevicesMember2025-01-012025-06-300001982444bdmd:DistributorsMember2025-01-012025-06-300001982444bdmd:DirectCustomersMember2025-01-012025-06-300001982444us-gaap:TransferredOverTimeMember2024-01-012024-06-300001982444us-gaap:TransferredAtPointInTimeMember2024-01-012024-06-300001982444bdmd:OtherMedicalDevicesMember2024-01-012024-06-300001982444bdmd:MicrowaveAblationTherapeuticApparatusMember2024-01-012024-06-300001982444bdmd:MicrowaveAblationNeedlesMember2024-01-012024-06-300001982444bdmd:MicrowaveAblationDevicesMember2024-01-012024-06-300001982444bdmd:DistributorsMember2024-01-012024-06-300001982444bdmd:DirectCustomersMember2024-01-012024-06-300001982444srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2025-06-300001982444srt:MinimumMemberus-gaap:EquipmentMember2025-06-300001982444srt:MinimumMemberbdmd:MedicalEquipmentMember2025-06-300001982444srt:MaximumMemberus-gaap:LeaseholdImprovementsMember2025-06-300001982444srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2025-06-300001982444srt:MaximumMemberus-gaap:EquipmentMember2025-06-300001982444srt:MaximumMemberbdmd:MedicalEquipmentMember2025-06-300001982444us-gaap:VehiclesMember2025-06-300001982444us-gaap:LeaseholdImprovementsMember2025-06-300001982444us-gaap:FurnitureAndFixturesMember2025-06-300001982444us-gaap:EquipmentMember2025-06-300001982444bdmd:MedicalEquipmentMember2025-06-300001982444us-gaap:VehiclesMember2024-12-310001982444us-gaap:LeaseholdImprovementsMember2024-12-310001982444us-gaap:FurnitureAndFixturesMember2024-12-310001982444us-gaap:EquipmentMember2024-12-310001982444bdmd:MedicalEquipmentMember2024-12-310001982444us-gaap:NoncontrollingInterestMember2025-01-012025-06-300001982444us-gaap:NoncontrollingInterestMember2024-01-012024-06-300001982444bdmd:GrandFortuneCapitalLlcMemberus-gaap:SeriesAPreferredStockMember2024-09-300001982444us-gaap:SeriesAPreferredStockMember2024-09-300001982444bdmd:HaimeiWuMemberus-gaap:RelatedPartyMember2023-12-310001982444bdmd:BettersMedicalInvestmentHoldingsLimitedMemberus-gaap:RelatedPartyMember2025-06-300001982444us-gaap:RelatedPartyMember2025-06-300001982444bdmd:BettersMedicalInvestmentHoldingsLimitedMemberus-gaap:RelatedPartyMember2024-12-310001982444us-gaap:RelatedPartyMember2024-12-310001982444us-gaap:ParentMember2025-01-012025-06-300001982444us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-300001982444us-gaap:ParentMember2024-01-012024-06-300001982444us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300001982444bdmd:TycoonChoiceGlobalLimitedMember2025-06-300001982444bdmd:SuzhouKangchuangMedicalCompanyLimitedMember2025-06-300001982444bdmd:ShengdeGuangzhouMedicalTechnologyCompanyLimitedMember2025-06-300001982444bdmd:RuikedeBiologicalTechnologyXiamenCompanyLimitedMember2025-06-300001982444bdmd:NanjingChangchengMedicalEquipmentCompanyLimitedMember2025-06-300001982444bdmd:JundeGuangzhouMedicalTechnologyCompanyLimitedMember2025-06-300001982444bdmd:HunanBaideMedicalTechnologyCompanyLimitedMember2025-06-300001982444bdmd:HenanRuideMedicalInstrumentCompanyLimitedMember2025-06-300001982444bdmd:HainanHaikeBaideMedicalCompanyLimitedMember2025-06-300001982444bdmd:GuokeBaideGuangdongMedicalCompanyLimitedMember2025-06-300001982444bdmd:GuizhouBaiyuanMedicalCompanyLimitedMember2025-06-300001982444bdmd:GuangzhouZhengdeCorporateManagementCompanyLimitedMember2025-06-300001982444bdmd:GuangzhouYideCapitalManagementCompanyLimitedMember2025-06-300001982444bdmd:GuangzhouFangdaMedicalTechnologyCompanyLimitedMember2025-06-300001982444bdmd:GuangzhouDedaoCapitalManagementCompanyLimitedMember2025-06-300001982444bdmd:GuangzhouBaihuiCorporateManagementCompanyLimitedMember2025-06-300001982444bdmd:ExcelfinAcquisitionCorpMember2025-06-300001982444bdmd:BettersMedicalNewcoLlcMember2025-06-300001982444bdmd:BairdMedicalLlcMember2025-06-300001982444bdmd:BaideSuzhouMedicalCompanyLimitedMember2025-06-300001982444bdmd:BaideMedicalInvestmentCompanyLimitedMember2025-06-300001982444bdmd:BaideGuangdongCapitalManagementCompanyLimitedMember2025-06-300001982444bdmd:WangJingMemberbdmd:RuikedeXiamenMember2019-07-170001982444bdmd:BankLoansMember2025-06-300001982444bdmd:FinancialLiabilitiesMember2024-12-310001982444bdmd:BankLoansMember2024-12-310001982444country:KY2025-01-012025-06-300001982444country:HK2025-01-012025-06-300001982444country:HK2024-01-012024-06-300001982444srt:MinimumMember2025-06-300001982444srt:MaximumMember2025-06-300001982444us-gaap:PatentsMember2025-06-300001982444us-gaap:ComputerSoftwareIntangibleAssetMember2025-06-300001982444us-gaap:PatentsMember2024-12-310001982444us-gaap:ComputerSoftwareIntangibleAssetMember2024-12-310001982444bdmd:NanjingChangchengMemberbdmd:ShortTermDebt2.8PercentDueInTenMonthsMemberus-gaap:SubsequentEventMember2025-10-012025-10-310001982444bdmd:NanjingChangchengMemberbdmd:ShortTermDebt2.8PercentDueInTenMonthsMemberus-gaap:SubsequentEventMember2025-10-310001982444bdmd:ShortTermDebt4.05PercentDue19thAugust2025Member2025-06-300001982444bdmd:ShortTermDebt3.85PercentDue19thNovember2025Member2025-06-300001982444bdmd:ShortTermDebt3.60PercentDue10thFebruary2026Member2025-06-300001982444bdmd:ShortTermDebt3.50PercentDue25thFebruary2026Member2025-06-300001982444bdmd:ShortTermDebt3.50PercentDue24thMarch2026Member2025-06-300001982444bdmd:ShortTermDebt3.50PercentDue14thMay2026Member2025-06-300001982444bdmd:ShortTermDebt3.30PercentDue3rdDecember2025Member2025-06-300001982444bdmd:ShortTermDebt3.10PercentDue5thDecember2025Member2025-06-300001982444bdmd:ShortTermDebt3.01PercentDue13thMarch2026Member2025-06-300001982444bdmd:ShortTermDebt3.00PercentDue27thDecember2025Member2025-06-300001982444bdmd:ShortTermDebt3.00PercentDue25thDecember2025Member2025-06-300001982444bdmd:ShortTermDebt2.80PercentDue20thMay2026Member2025-06-300001982444bdmd:ShortTermDebt2.80PercentDue11thJune2026Member2025-06-300001982444bdmd:ShortTermDebt2.55PercentDue5thNovember2025Member2025-06-300001982444bdmd:ShortTermDebt2.55PercentDue28thOctober2025Member2025-06-300001982444bdmd:ShortTermDebt4.15PercentDue27thMarch2025Member2024-12-310001982444bdmd:ShortTermDebt4.10PercentDue25thApril2025Member2024-12-310001982444bdmd:ShortTermDebt4.05PercentDue19thAugust2025Member2024-12-310001982444bdmd:ShortTermDebt3.95PercentDue14thMay2025Member2024-12-310001982444bdmd:ShortTermDebt3.90PercentDue29thJanuary2025Member2024-12-310001982444bdmd:ShortTermDebt3.85PercentDue19thNovember2025Member2024-12-310001982444bdmd:ShortTermDebt3.40PercentDue6thMay2025Member2024-12-310001982444bdmd:ShortTermDebt3.40PercentDue11thMay2025Member2024-12-310001982444bdmd:ShortTermDebt3.36PercentDue20thJune2025OneMember2024-12-310001982444bdmd:ShortTermDebt3.36PercentDue20thJune2025Member2024-12-310001982444bdmd:ShortTermDebt3.30PercentDue3rdDecember2025Member2024-12-310001982444bdmd:ShortTermDebt3.10PercentDue5thDecember2025Member2024-12-310001982444bdmd:ShortTermDebt3.00PercentDue26thMarch2025Member2024-12-310001982444bdmd:ShortTermDebt3.00PercentDue26thJune2025Member2024-12-310001982444bdmd:ShortTermDebt3.00PercentDue25thDecember2025Member2024-12-310001982444bdmd:ShortTermDebt3.00PercentDue11thJanuary2025Member2024-12-310001982444bdmd:ShortTermDebt2.55PercentDue5thNovember2025Member2024-12-310001982444bdmd:ShortTermDebt2.55PercentDue5thMay2025Member2024-12-310001982444bdmd:ShortTermDebt2.55PercentDue28thOctober2025Member2024-12-310001982444bdmd:ShortTermDebt2.55PercentDue13thMarch2025Member2024-12-310001982444bdmd:LongTermBankLoans3.10PercentIssuedOn18thDecember2024Due17thDecember2027Member2025-06-300001982444bdmd:LongTermBankLoans2.90PercentIssuedOn31stMarch2025Due30thMarch2028Member2025-06-300001982444bdmd:LongTermBankLoans2.90PercentIssuedOn14thApril2025Due30thMarch2028Member2025-06-300001982444bdmd:FinancialLiabilitiesMember2025-06-300001982444us-gaap:OperatingSegmentsMember2025-01-012025-06-300001982444us-gaap:OperatingSegmentsMember2024-01-012024-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorTwoMember2025-01-012025-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorThreeMember2025-01-012025-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorOneMember2025-01-012025-06-300001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorTwoMember2025-01-012025-06-300001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorThreeMember2025-01-012025-06-300001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorOneMember2025-01-012025-06-300001982444bdmd:CustomerTwoMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-06-300001982444bdmd:CustomerTwoMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-06-300001982444bdmd:CustomerOneMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-06-300001982444bdmd:CustomerOneMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-06-300001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorTwoMember2024-01-012024-12-310001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorOneMember2024-01-012024-12-310001982444bdmd:CustomerTwoMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310001982444bdmd:CustomerThreeMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310001982444bdmd:CustomerOneMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorTwoMember2024-01-012024-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorThreeMember2024-01-012024-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorOneMember2024-01-012024-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorFourMember2024-01-012024-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorFiveMember2024-01-012024-06-300001982444bdmd:CustomerTwoMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-06-300001982444bdmd:CustomerThreeMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-06-300001982444bdmd:CustomerOneMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-06-300001982444bdmd:CustomerFourMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-06-300001982444srt:ParentCompanyMembersrt:ReportableLegalEntitiesMember2025-01-012025-06-300001982444srt:ParentCompanyMembersrt:ReportableLegalEntitiesMember2024-01-012024-06-3000019824442024-09-300001982444bdmd:J.v.b.FinancialGroupLlcMember2025-06-300001982444bdmd:GrandFortuneCapitalH.k.CompanyLimitedMember2025-06-300001982444bdmd:EquityIncentivePlan2024Member2025-06-300001982444bdmd:PublicStockholdersMemberbdmd:ExcelfinAcquisitionCorpMember2024-10-010001982444bdmd:ExcelfinPublicWarrantsMember2025-06-300001982444bdmd:ExcelfinAcquisitionCorpMemberbdmd:PublicWarrantsMember2024-10-0100019824442023-08-030001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2019-07-170001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2022-01-012022-12-310001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2025-06-300001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2024-12-310001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2022-11-252022-11-250001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2022-12-310001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2022-11-250001982444bdmd:ExcelfinPublicWarrantsMember2025-01-012025-06-3000019824442025-04-012025-09-300001982444us-gaap:RestrictedStockUnitsRSUMemberbdmd:EquityIncentivePlan2024Member2025-01-012025-06-300001982444us-gaap:GeneralAndAdministrativeExpenseMember2025-01-012025-06-300001982444us-gaap:RestrictedStockUnitsRSUMemberbdmd:EquityIncentivePlan2024Member2024-01-012024-06-3000019824442024-01-012024-12-310001982444srt:ParentCompanyMembersrt:ReportableLegalEntitiesMember2025-06-300001982444bdmd:ChinaCiticBankMemberus-gaap:AssetPledgedAsCollateralMember2023-12-290001982444us-gaap:FinancialAssetNotPastDueMember2025-06-300001982444bdmd:FinancialAssetWithin90PastDueMember2025-06-300001982444bdmd:FinancialAssetGreaterThanOneYearPastDueMember2025-06-300001982444bdmd:FinancialAssetBetween6MonthsAndOneYearPastDueMember2025-06-300001982444bdmd:FinancialAssetBetween3And6MonthsPastDueMember2025-06-300001982444us-gaap:FinancialAssetNotPastDueMember2024-12-310001982444bdmd:FinancialAssetWithin90PastDueMember2024-12-310001982444bdmd:FinancialAssetGreaterThanOneYearPastDueMember2024-12-310001982444bdmd:FinancialAssetBetween6MonthsAndOneYearPastDueMember2024-12-310001982444bdmd:FinancialAssetBetween3And6MonthsPastDueMember2024-12-310001982444us-gaap:SupplierConcentrationRiskMember2025-06-300001982444us-gaap:SupplierConcentrationRiskMember2024-12-310001982444country:HKbdmd:UpToFirstHkd2MillionProfitsMember2025-01-012025-06-300001982444srt:MinimumMemberbdmd:ExcelfinAcquisitionCorpMember2024-10-012024-10-010001982444srt:MinimumMember2024-10-012024-10-010001982444bdmd:BettersMedicalNewcoLlcMembersrt:MinimumMember2023-08-032023-08-0300019824442023-08-032023-08-030001982444bdmd:GrandFortuneCapitalLlcMemberus-gaap:SeriesAPreferredStockMember2024-09-302024-09-3000019824442024-09-262024-09-260001982444bdmd:BaideSuzhouMember2025-02-280001982444bdmd:NanjingChangchengMember2023-09-012023-09-300001982444bdmd:NanjingChangchengMember2025-06-300001982444bdmd:BaideSuzhouMember2025-01-310001982444bdmd:NanjingChangchengMember2023-09-300001982444bdmd:HaimeiWuMemberus-gaap:RelatedPartyMember2024-01-012024-06-300001982444us-gaap:SeriesAPreferredStockMember2024-09-302024-09-300001982444country:CN2025-01-012025-06-300001982444country:CN2024-01-012024-06-300001982444bdmd:WuWenyuanMemberus-gaap:SeriesAPreferredStockMember2024-09-302024-09-300001982444bdmd:WuWenyuanMemberus-gaap:SeriesAPreferredStockMember2024-09-300001982444bdmd:ExcelfinAcquisitionCorpMember2024-01-012024-12-310001982444country:US2025-01-012025-06-300001982444country:US2024-01-012024-06-300001982444country:HKbdmd:ProfitsAboveHkd2MillionMember2025-01-012025-06-3000019824442024-10-012024-10-010001982444bdmd:BettersMedicalNewcoLlcMember2025-01-012025-06-300001982444bdmd:BettersMedicalNewcoLlcMember2023-08-032023-08-0300019824442024-06-3000019824442023-12-310001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMember2025-01-012025-06-300001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMember2025-01-012025-06-300001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMember2024-01-012024-12-310001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMember2024-01-012024-06-300001982444us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-06-300001982444us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-06-300001982444us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310001982444us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-06-3000019824442024-10-010001982444srt:ParentCompanyMembersrt:ReportableLegalEntitiesMember2024-12-310001982444bdmd:ExcelfinAcquisitionCorpMemberbdmd:PublicWarrantsMember2024-10-012024-10-010001982444bdmd:ExcelfinAcquisitionCorpMember2024-12-310001982444bdmd:ExcelfinAcquisitionCorpMember2023-08-032023-08-030001982444bdmd:ExcelfinAcquisitionCorpMember2024-10-012024-10-010001982444country:CNbdmd:ProfitsExceedingRmb1MillionAndUpToRmb3MillionMember2025-01-012025-06-300001982444country:CNbdmd:UpToFirstRmb3MillionProfitsMember2025-01-012025-06-300001982444country:CNbdmd:UpToFirstRmb1MillionProfitsMember2025-01-012025-06-300001982444us-gaap:RetainedEarningsMember2025-01-012025-06-300001982444bdmd:StatutoryReserveMember2025-01-012025-06-300001982444us-gaap:RetainedEarningsMember2024-01-012024-06-300001982444bdmd:StatutoryReserveMember2024-01-012024-06-300001982444bdmd:ExcelfinAcquisitionCorpMember2024-10-0100019824442025-06-3000019824442024-12-310001982444srt:MinimumMember2025-01-012025-06-300001982444srt:MaximumMember2025-01-012025-06-300001982444srt:MinimumMember2024-01-012024-06-300001982444srt:MaximumMember2024-01-012024-06-3000019824442024-01-012024-06-30bdmd:periodbdmd:Dbdmd:segmentiso4217:USDxbrli:sharesxbrli:pureiso4217:USDxbrli:sharesbdmd:customerbdmd:itemiso4217:CNYiso4217:HKDbdmd:subsidiary

    ​

    ​

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    ​

    FORM 6-K

    ​

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    OF THE SECURITIES EXCHANGE ACT OF 1934

    ​

    For the month of December 2025

    Commission File Number 001-42300

    ​

    Baird Medical Investment Holdings Limited

    ​

    Room 202, 2/F, Baide Building, Building 11, No.15

    Rongtong Street, Yuexiu District, Guangzhou,

    Peoples Republic of China

    (Address of principal executive offices)

    ​

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

    ​

    Form 20-F   ☒

    Form 40-F   ☐

    ​

    ​

    ​

    ​

    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: December 5, 2025

     

     

     

     

    By:

    /s/ Haimei Wu

     

    Name: Haimei Wu

     

    Title: Chairwoman and Chief Executive Officer

    ​

    ​

    ​

    EXHIBIT INDEX

    ​

    ​

    ​

    Exhibit
    Number

    ​

    Description

    99.1

    ​

    Unaudited Interim Consolidated Financial Statements as of December 31, 2024 and June 30, 2025, and the for the Six Months Ended June 30, 2024 and 2025

    99.2

    ​

    Management’s Discussion and Analysis of Financial Condition and Results of Operations

    101.INS

    ​

    Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

    101.SCH

    ​

    Inline XBRL Taxonomy Extension Schema Document

    101.CAL

    ​

    Inline XBRL Taxonomy Extension Calculation Linkbase Document

    101.DEF

    ​

    Inline XBRL Taxonomy Extension Definition Linkbase Document

    101.LAB

    ​

    Inline XBRL Taxonomy Extension Label Linkbase Document

    101.PRE

    ​

    Inline XBRL Taxonomy Extension Presentation Linkbase Document

    104

    ​

    Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

    ​

    ​

    ​

    Get the next $BDMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BDMD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BDMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026

    NEW YORK, March 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful strategic showcase at the 2026 North American Society for Interventional Thyroidology (NASIT) in Portland, Oregon. This engagement advances the Company's goal to expand patient access to advanced, minimally invasive treatment options. Baird Medical's proprietary MWA platforms garnered significant interest during the event's thermal ablation worksho

    3/9/26 8:30:00 AM ET
    $BDMD
    Medical/Dental Instruments
    Health Care

    Baird Medical Accelerates Global Registration of AI-Driven Surgical Software

    NEW YORK, March 4, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of development for its cross-platform surgical software, officially commencing the registration process in the United States, the European Union, and China. Leveraging a proprietary artificial intelligence model, the system automates core clinical workflows, including anatomical mapping, dynamic treatment planning, and procedural simulations. By integrat

    3/4/26 8:30:00 AM ET
    $BDMD
    Medical/Dental Instruments
    Health Care

    Baird Medical Accelerates U.S. Expansion at NASOIE 2026

    NEW YORK, March 2, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation at the 2026 North American Society of Interventional Endocrinologists (NASOIE) Annual Meeting in Miami, Florida. Building on successful engagements at previous NASOIE gatherings, this initiative reinforces the Company's enduring commitment to physician education and advances its strategy to expand patient access to minimally invasive therapies.

    3/2/26 8:30:00 AM ET
    $BDMD
    Medical/Dental Instruments
    Health Care

    $BDMD
    SEC Filings

    View All

    SEC Form S-8 filed by Baird Medical Investment Holdings Ltd

    S-8 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

    3/10/26 8:43:55 AM ET
    $BDMD
    Medical/Dental Instruments
    Health Care

    SEC Form 6-K filed by Baird Medical Investment Holdings Ltd

    6-K - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

    2/10/26 7:59:47 AM ET
    $BDMD
    Medical/Dental Instruments
    Health Care

    SEC Form 424B3 filed by Baird Medical Investment Holdings Ltd

    424B3 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

    1/16/26 4:32:46 PM ET
    $BDMD
    Medical/Dental Instruments
    Health Care

    $BDMD
    Leadership Updates

    Live Leadership Updates

    View All

    Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion

    NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the appointment of Mark Saxton as Chief Executive Officer of its U.S. subsidiary. Mr. Saxton is a seasoned medical device executive with more than 25 years of commercial leadership experience, including a decade advancing intravascular RF ablation technologies. He will lead all U.S. operations, including sales, marketing, and market development, as Baird Medical

    12/3/25 8:30:00 AM ET
    $BDMD
    Medical/Dental Instruments
    Health Care

    Baird Medical Champions Global Collaboration in Microwave Ablation at International Thyroid Workshop

    NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation in the 3rd International Workshop on Thermal Ablation of Thyroid Tumor and Hyperparathyroidism. The prestigious academic event was hosted by the China-Japan Friendship Hospital in Beijing, China, from October 17-18, 2025. Chaired by Prof. Ming'an Yu, a leading authority in interventional medicine, the workshop served as a vital platform for the world's foremost experts to share

    10/20/25 8:30:00 AM ET
    $BDMD
    Medical/Dental Instruments
    Health Care